Assessment of lifestyle-related risk factors enhances the effectiveness of cardiac stress Article

Full Text via DOI: 10.1016/j.pcad.2023.03.004 Web of Science: 001012319700001

Cited authors

  • Rozanski A, Sakul S, Narula J, Uretsky S, Lavie CJ, Berman D

Abstract

  • Cardiac stress tests have been widely utilized since the 1960s for the diagnostic and prognostic assessment of pa-tients with suspected coronary artery disease (CAD). Clinical risk is primarily based on assessing the presence and magnitude of inducible myocardial ischemia. However, the primary factors driving mortality risk have changed over recent decades. Factors such as typical angina and inducible ischemia have decreased, whereas the percent-age of patients with diabetes, obesity and hypertension have increased. There has also been a marked temporal increase in the percentage of patients who require pharmacologic testing due to inability to perform treadmill exercise at the time of cardiac stress testing and this need has emerged as the most potent predictor of mortality risk in contemporary stress test populations. However, the long-term clinical risk posed by the inability to per-form exercise and concomitant CAD risk factors are rarely reflected in the assessment of patients' prognostic risk in cardiac stress test reports. In this review, we suggest that the clinical utility of present-day cardiac stress testing can be improved by developing a more comprehensive assessment that integrates and reports all factors which modulate patients' long-term clinical risk following stress and testing. This should include assessment of patients' CAD risk factors, physical activity habits and mobility risks, and identification of the reasons why patients could not exercise at the time of cardiac stress testing. In addition, the assessment of four core non -aerobic functional parameters should be considered among patients who cannot exercise: assessment of gait speed, handgrip strength, lower extremity strength, and standing balance. & COPY; 2023 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).

Publication date

  • 2023

Published in

International Standard Serial Number (ISSN)

  • 0033-0620

Number of pages

  • 12

Start page

  • 95

End page

  • 106

Volume

  • 77